Subbaramaiah K - Search Results

1

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ. Howe LR, et al. Among authors: subbaramaiah k. Cancer Res. 2002 Oct 1;62(19):5405-7. Cancer Res. 2002. PMID: 12359744

2

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Subbaramaiah K, et al. J Biol Chem. 2002 May 24;277(21):18649-57. doi: 10.1074/jbc.M111415200. Epub 2002 Mar 18. J Biol Chem. 2002. PMID: 11901151 Free article.

3

Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms.

Subbaramaiah K, Cole PA, Dannenberg AJ. Subbaramaiah K, et al. Cancer Res. 2002 May 1;62(9):2522-30. Cancer Res. 2002. PMID: 11980644

4

Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

Subbaramaiah K, Dannenberg AJ. Subbaramaiah K, et al. Trends Pharmacol Sci. 2003 Feb;24(2):96-102. doi: 10.1016/S0165-6147(02)00043-3. Trends Pharmacol Sci. 2003. PMID: 12559775 Review.

5

Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism.

De Lorenzo MS, Yamaguchi K, Subbaramaiah K, Dannenberg AJ. De Lorenzo MS, et al. Among authors: subbaramaiah k. Clin Cancer Res. 2003 Oct 15;9(13):5036-43. Clin Cancer Res. 2003. PMID: 14581379

6

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.

Dannenberg AJ, Subbaramaiah K. Dannenberg AJ, et al. Among authors: subbaramaiah k. Cancer Cell. 2003 Dec;4(6):431-6. doi: 10.1016/s1535-6108(03)00310-6. Cancer Cell. 2003. PMID: 14706335 Free article. Review. No abstract available.

7

Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.

Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, Seidman AD, D'Andrea GM, Theodoulou M, Panageas KS, Norton L, Hudis CA. Dang CT, et al. Among authors: subbaramaiah k. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4062-7. doi: 10.1158/1078-0432.CCR-03-0463. Clin Cancer Res. 2004. PMID: 15217939 Clinical Trial.

8

Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands.

Moraitis D, Du B, De Lorenzo MS, Boyle JO, Weksler BB, Cohen EG, Carew JF, Altorki NK, Kopelovich L, Subbaramaiah K, Dannenberg AJ. Moraitis D, et al. Among authors: subbaramaiah k. Cancer Res. 2005 Jan 15;65(2):664-70. Cancer Res. 2005. PMID: 15695412

9

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.

Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ. Patel MI, et al. Among authors: subbaramaiah k. Clin Cancer Res. 2005 Mar 1;11(5):1999-2007. doi: 10.1158/1078-0432.CCR-04-1877. Clin Cancer Res. 2005. PMID: 15756026

10

Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.

Altorki NK, Port JL, Zhang F, Golijanin D, Thaler HT, Duffield-Lillico AJ, Subbaramaiah K, Dannenberg AJ. Altorki NK, et al. Among authors: subbaramaiah k. Clin Cancer Res. 2005 Jun 1;11(11):4191-7. doi: 10.1158/1078-0432.CCR-05-0108. Clin Cancer Res. 2005. PMID: 15930356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters